 |
 |

Diploid Cell Measles Vaccine
Jorge Fernández de Castro, MD;
José Luis Valdespino Gómez, MD;
José Luis Díaz Ortega, MD;
Ma. Luisa Zárate Aquino, MD
Secretaria de Salud; Secretaria de Salud;Instituto de Salubridad Mexico City
JAMA. 1986;256(6):714.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
To the Editor.—
Dr Albert Sabin and one of us (J.F.D.)1,2 recently reported seroconversion in infants administered measles vaccine of human diploid cells (HDCs) that contained the Iki (Edmonston-Zagreb) strain and 1% human albumin, or chick embryo fibroblast (CEF) vaccine that contained the Edmonston-Schwartz strain by cutaneous or aerosol routes. In that study, we used enzyme-linked immunosorbent assay and plaque neutralization tests to demonstrate seroconversion. In this letter we report a further study in which antibody was measured using the more standard hemagglutination inhibition. This double-blind study was carried out in children aged 6 to 8 months residing in two poor urban areas of Mexico City between October 1983 and April 1984.
Report of a Case.—
One hundred seventy-two children received HDC vaccine manufactured in Mexico: 117 via aerosol (titer of virus, 105.2 50% tissue culture infective dose per milliliter), and 55 by injection (titer of virus, 10
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|